DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

被引：0
|
作者：
Christine Aaserød Pedersen
Maria Dung Cao
Thomas Fleischer
Morten B. Rye
Stian Knappskog
Hans Petter Eikesdal
Per Eystein Lønning
Jörg Tost
Vessela N. Kristensen
May-Britt Tessem
Guro F. Giskeødegård
Tone F. Bathen
机构：
[1] NTNU - Norwegian University of Science and Technology,Department of Circulation and Medical Imaging
[2] Østfold University College,Department of Nursing, Health and Laboratory Science
[3] Oslo University Hospital,Department of Cancer Genetics, Institute for Cancer Research
[4] Trondheim University Hospital,Clinic of Surgery, St. Olavs Hospital
[5] NTNU – Norwegian University of Science and Technology,Department of Clinical and Molecular Medicine
[6] Trondheim University Hospital,Clinic of Laboratory Medicine, St. Olavs Hospital
[7] NTNU – Norwegian University of Science and Technology,BioCore
[8] University of Bergen, Bioinformatics Core Facility
[9] Haukeland University Hospital,K.G. Jebsen Centre for Genome
[10] Université Paris Saclay,Directed Cancer Therapy, Department of Clinical Science
[11] Oslo University Hospital,Department of Oncology
[12] NTNU - Norwegian University of Science and Technology,Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humaine, CEA – Institut de Biologie François Jacob
[13] St. Olavs Hospital,Department of Medical Genetics, Institute of Clinical Medicine
[14] Trondheim University Hospital,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, and Nursing
来源：
Breast Cancer Research | / 24卷
关键词：
DNA methylation; Locally advanced breast cancer; Survival; Treatment response; Breast cancer; Neoadjuvant chemotherapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution
    Prihantono
    Faruk, Muhammad
    SURGERY OPEN SCIENCE, 2023, 15 : 19 - 25
  • [32] Development of DNA methylation signature predictive of response to neoadjuvant chemotherapy in osteosarcoma
    Jolivet, Philippe
    Garzia, Livia
    Jung, Sungmi
    Kleinman, Claudia
    Howitt, Brooke
    Jabado, Nada
    Rak, Janusz
    Przybyl, Joanna
    CANCER RESEARCH, 2024, 84 (17)
  • [33] Tumour DNA methylation markers associated with breast cancer survival: a replication study
    Zarean, Elaheh
    Li, Shuai
    Wong, Ee Ming
    Makalic, Enes
    Milne, Roger L.
    Giles, Graham G.
    Mclean, Catriona
    Southey, Melissa C.
    Dugue, Pierre-Antoine
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [34] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Wilson Eduardo Furlan Matos Alves
    Murilo Bonatelli
    Rozany Dufloth
    Lígia Maria Kerr
    Guilherme Freire Angotti Carrara
    Ricardo Filipe Alves da Costa
    Cristovam Scapulatempo-Neto
    Daniel Tiezzi
    René Aloísio da Costa Vieira
    Céline Pinheiro
    BMC Cancer, 19
  • [35] Biomarker Changes After Neoadjuvant Chemotherapy for Breast Cancer
    Maguire, Aoife
    Hudson, Andrew
    Jagas, Jacob
    Quinn, Cecily
    LABORATORY INVESTIGATION, 2023, 103 (03) : S178 - S178
  • [36] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Furlan Matos Alves, Wilson Eduardo
    Bonatelli, Murilo
    Dufloth, Rozany
    Kerr, Ligia Maria
    Angotti Carrara, Guilherme Freire
    Alves da Costa, Ricardo Filipe
    Scapulatempo-Neto, Cristovam
    Tiezzi, Daniel
    da Costa Vieira, Rene Aloisio
    Pinheiro, Celine
    BMC CANCER, 2019, 19 (01)
  • [37] Transcriptomic and functional pathway features were associated with survival after pathological complete response to neoadjuvant chemotherapy in breast cancer
    Takeshita, Takashi
    Yan, Li
    Peng, Xuan
    Kimbung, Siker
    Hatschek, Thomas
    Hedenfalk, Ingrid A.
    Rashid, Omar M.
    Takabe, Kazuaki
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (08): : 2555 - +
  • [38] Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer
    Flanagan, James M.
    Wilson, Angela
    Koo, Chail
    Masrour, Nahal
    Gallon, John
    Loomis, Erick
    Flower, Kirsty
    Wilhelm-Benartzi, Charlotte
    Hergovich, Alexander
    Cunnea, Paula
    Gabra, Hani
    Braicu, Elena Ioana
    Sehouli, Jalid
    Darb-Esfahani, Silvia
    Vanderstichele, Adriaan
    Vergote, Ignace
    Kreuzinger, Caroline
    Castillo-Tong, Dan Cacsire
    Wisman, G. Bea A.
    Berns, Els Mjj
    Siddiqui, Nadeem
    Paul, James
    Brown, Robert
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2213 - 2222
  • [39] Neoadjuvant chemotherapy induces changes in expression of breast cancer resistance protein that predict disease free survival in breast cancer
    Kim, B.
    Williams, B. J.
    Fatayer, H.
    Hanby, A. M.
    Horgan, K.
    Thorne, J. L.
    Valleley, E. M. A.
    Verghese, E. T.
    Hughes, T. A.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 2 - 2
  • [40] Neoadjuvant Chemotherapy Induces Changes in Expression of Breast Cancer Resistance Protein that Predict Disease Free Survival in Breast Cancer
    Kim, B.
    Williams, B. J.
    Fatayer, H.
    Hanby, A. M.
    Horgan, K.
    Thorne, J. L.
    Valleley, E. M. A.
    Verghese, E. T.
    Hughes, T. A.
    JOURNAL OF PATHOLOGY, 2013, 229 : S6 - S6
12345